Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureDylan Vellas, Audrey Bergès, Yann De Rycke, Sandrine Pinto, Antoine Rozes, Mathieu Tronchon, Sylvain Dubucquoi, Cécile Contin-Bordes, Thierry Vincent, Alexandre Jentzer, Daniela Lakomy, Benoit Nespola, Nathalie Bardin, Daniel Bertin, Fabienne Jouen, Olivier Boyer, Pascale Ghillani-Dalbin, Jean-Luc Charuel, Chantal Dumestre-Perard, Giovanna Clavarino, Pascale Nicaise, Pascale Chrétien, Claire Goulvestre, Anne-Emmanuelle Berger, Frédéric Coutant, Nicole Fabien, Olivier Benveniste, Yves Allenbach
Abstract
Research graph
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study
10.1136/annrheumdis-2017-211402 · 2018
Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study
10.1093/rheumatology/kew503 · 2017
Evaluation and construction of diagnostic criteria for inclusion body myositis
10.1212/wnl.0000000000000642 · 2014
224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies, Zandvoort, the Netherlands, 14-16 October 2016
10.1016/j.nmd.2017.09.016 · 2018
239th ENMC International workshop: classification of dermatomyositis, amsterdam, the Netherlands, 14-16 December 2018
10.1016/j.nmd.2019.10.005 · 2020
Myositis-related interstitial lung disease and antisynthetase syndrome
10.1590/s1806-37132011000100015 · 2011
Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies
10.1001/jamaneurol.2018.2598 · 2018
HLA association with autoimmune diseases
2013
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups
10.1136/annrheumdis-2015-208119 · 2016
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
10.1136/annrheumdis-2021-219914 · 2021
Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study
10.1136/annrheumdis-2017-211174 · 2017
The seasonality of dermatomyositis associated with anti-MDA5 antibody: an argument for a respiratory viral trigger
10.1016/j.autrev.2021.102788 · 2021
Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
10.1016/j.respe.2017.05.004 · 2017
256th ENMC international workshop: myositis specific and associated autoantibodies (MSA-ab), Amsterdam, the Netherlands, 8-10 October 2021
10.1016/j.nmd.2022.05.011 · 2022
Unresolved referenced work
Kept as external metadata until matched
Robust locally weighted regression and smoothing scatterplots
10.1080/01621459.1979.10481038 · 1979
Tests of equality between sets of coefficients in two linear regressions
10.2307/1910133 · 1960
Selective review of offline change point detection methods
10.1016/j.sigpro.2019.107299 · 2020
Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience
2023
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
10.1038/s41467-020-19741-6 · 2020
A review of myositis-associated interstitial lung disease
10.3390/jcm13144055 · 2024
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study
10.1016/j.jaut.2023.103081 · 2023
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
10.1016/j.ebiom.2024.105136 · 2024
Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays
10.1016/j.autrev.2018.10.004 · 2019
Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review
10.3389/fimmu.2024.1428645 · 2024
Myositis-specific autoantibodies: detection and clinical associations
10.1007/s13317-011-0018-8 · 2011
Multipositivité des anticorps spécifiques des myosites recherchés par immunoblot : séroprévalence et signification clinique
10.1016/j.revmed.2020.10.055 · 2020
The role of myositis-specific and myositis-associated autoantibodies and the activation of type I interferon pathway in the generation of clinical phenotypes of inflammatory myopathies
10.31138/mjr.34.2.275 · 2023
KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
10.1126/science.abi9591 · 2022
No additional external references are available.